Abstract
Objective
There is mounting evidence showing the value of low-dose corticosteroids in patients with septic shock requiring vasopressor therapy. It remains unclear whether adrenal function tests should be carried out systematically to guide the decision on glucocorticoid therapy.
Methods
The retrospective study was conducted in 52 patients in three university hospital ICUs. We included consecutive patients with catecholamine-dependent septic shock who had not received ketoconazole, glucocorticoids, or etomidate in the 24 h before the ACTH test, and who had survived to day 3 after the shock onset. All patients had a 250-μg ACTH test before systematic glucocorticoid therapy was started. Various definitions of relative adrenal insufficiency were used (based on cortisol basal level and/or change in cortisol level after ACTH stimulation). We defined hemodynamic improvement as a 50% reduction in the vasoactive agent dose in the 3 days following the initiation of glucocorticoid treatment. The relationship between the hemodynamic improvement and the results of the adrenal function tests was analyzed.
Results
Hemodynamic improvement occurred in 29 patients (55.8%). Baseline characteristics, sites of infection, types of micro-organisms and antibiotic management did not differ between patients with and those without hemodynamic improvement. Relative adrenal insufficiency whatever the definition was not associated with hemodynamic improvement.
Conclusion
In catecholamine-dependent septic shock patients managed with systematic glucocorticoid therapy the results of ACTH stimulation do not predict hemodynamic improvement.
Similar content being viewed by others
References
Prigent H, Maxime V, Annane D (2004) Clinical review: corticotherapy in sepsis. Crit Care 8:122–129
Annane D, Sebille V, Troché G, Raphael JC, Gajdos P, Bellissant E (2000) A3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin JAMA 283:1038–1045
Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871
Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2004) Corticosteroids for treating severe sepsis and septic shock (Cochrane Review). In: The Cochrane Library, issue 2. Wiley, Chichester
Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47–56
Keh D, Sprung CL (2004) Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence base review. Crit Care Med 32 [Suppl] 527–533
Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banaloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555
Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) reducing mortality in sepsis: new directions. Crit Care 6 [Suppl 3]:1–18
American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874
Raphael JC, Antony I, Bellissant E, Bonmarchand J, Cotting J, Fierobe L, Gouyon JB, Hasselmann G, Leleu G, Misset B, Thevenin D (1996) Utilisation des catecholamines au cours du choc septique (adultes-enfants) XVeme conference de consensus en réanimation et médecine d' urgence. Reanimation Soins Intensifs Med Urgence 5:441–450
McCabe WR, Jackson GG (1962) Gram-negative bacteraemia etiology and ecology. Arch Intern Med 110:847–852
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Vincent JL, Moreno R, Takala J, Wilatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710
Marik PE, Zaloga GP (2003) Adrenal insufficiency during septic shock. Crit Care Med 31:141–145
Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650
Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU (2000) Plasma cortisol levels before and during ‘low-dose’ hydrocortisone therapy and their relationship to haemodynamic improvement in patients with septic shock. Intensive Care Med 26:1747–1755
Luce JM (2004) Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed. Ann Intern Med 141:70–72
Annane D (2002) Cortisol replacement for severe sepsis and septic shock: what should I do? Crit Care 6:190–191
Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, Gajdos P (1998) impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 46:589–597
Annane D, Bellissant E (2000) Effect of hydrocortisone on phenylephrine-mean arterial pressure dose response relationship in septic shock. Clin Pharmacol Ther 68:293–303
Schenarts CL, Burton JH, Riker RR (2001) Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 8:1–7
Absalom A, Pledger D, Kong A (1999) Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 54:861–867
Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Levy B, Bollaert PE (2005) Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 31:388–392
Annane D (2005) ICU physicians should abandon the use of etomidate! Intensive Care Med 31:325–326
Cooper MS, Stewart PM (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727–734
Abraham E, Evans T (2002) Corticosteroids and septic shock. JAMA 288:886–887
Hamrahian AH, Oseni TS, Arafah BM (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350:1629–1638
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2000) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morel, J., Venet, C., Donati, Y. et al. Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 32, 1184–1190 (2006). https://doi.org/10.1007/s00134-006-0233-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0233-3